Roche's emicizumab hemophilia drug shows positive results with children

ZURICH (Reuters) - Roche Holding AG's emicizumab drug for treating hemophilia A showed positive interim results in a phase III study with children with inhibitors to clotting protein factor VIII, the Swiss drugmaker said on Monday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news